Molecular targets of biofabricated silver nanoparticles in Candida albicans

Shivkrupa D Halbandge1, Ashwini K Jadhav2, Priyanka M Jangid1

  • 1School of Life Sciences, SRTM University, Nanded, Maharashtra, 431606, India.

Insights

Biofabricated silver nanoparticles reduce the expression of key genes involved in Candida albicans morphogenesis. This suggests silver nanoparticles may be a novel strategy to decrease fungal virulence and treat infections.

Area of Science:

  • Microbiology
  • Nanotechnology
  • Molecular Biology

Background:

  • Candida albicans transitions between yeast and hyphal forms, a key factor in its virulence.
  • The Ras-cAMP-EFG1 and CEK1-MAPK pathways regulate this morphological switch.
  • Developing novel anti-fungal strategies is crucial due to increasing resistance.

Purpose of the Study:

  • To investigate the effect of biofabricated silver nanoparticles on gene expression during Candida albicans morphogenesis.
  • To determine if silver nanoparticles can modulate key pathways regulating yeast-to-hyphal transition.

Main Methods:

  • Analysis of gene expression profiles in Candida albicans treated with silver nanoparticles.
  • Focus on genes within the Ras-cAMP-EFG1 and CEK1-MAPK pathways.

Main Results:

  • Silver nanoparticles significantly downregulated genes essential for hyphal development, including ECE1 (5.1-fold) and TEC1 (6.28-fold).
  • Negative regulators of hyphal transition, TUP1 and RFG1, were also downregulated (2.45-fold and 5.43-fold, respectively).
  • Gene expression analysis revealed modulation of Ras-cAMP-EFG1 and CEK1-MAPK pathways.

Conclusions:

  • Biofabricated silver nanoparticles impact gene expression in Candida albicans, specifically downregulating morphogenesis-related genes.
  • Silver nanoparticles show potential for reducing Candida albicans virulence by targeting key regulatory pathways.
  • This study highlights silver nanoparticles as a promising therapeutic avenue for combating pathogenic fungal infections.